These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 34724929)

  • 1. Modification of improved-genome editing via oviductal nucleic acids delivery (i-GONAD)-mediated knock-in in rats.
    Aoshima T; Kobayashi Y; Takagi H; Iijima K; Sato M; Takabayashi S
    BMC Biotechnol; 2021 Nov; 21(1):63. PubMed ID: 34724929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful
    Takabayashi S; Iijima K; Tsujimura M; Aoshima T; Takagi H; Aoto K; Sato M
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential i-GONAD: An Improved In Vivo Technique for CRISPR/Cas9-Based Genetic Manipulations in Mice.
    Sato M; Miyagasako R; Takabayashi S; Ohtsuka M; Hatada I; Horii T
    Cells; 2020 Feb; 9(3):. PubMed ID: 32110989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GONAD: A new method for germline genome editing in mice and rats.
    Namba M; Kobayashi T; Koyano T; Kohno M; Ohtsuka M; Matsuyama M
    Dev Growth Differ; 2021 Oct; 63(8):439-447. PubMed ID: 34432885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved Genome Editing via Oviductal Nucleic Acids Delivery (i-GONAD): Protocol Steps and Additional Notes.
    Sato M; Nakamura A; Sekiguchi M; Matsuwaki T; Miura H; Gurumurthy CB; Kakuta S; Ohtsuka M
    Methods Mol Biol; 2023; 2631():325-340. PubMed ID: 36995675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. i-GONAD (improved genome-editing via oviductal nucleic acids delivery), a convenient in vivo tool to produce genome-edited rats.
    Takabayashi S; Aoshima T; Kabashima K; Aoto K; Ohtsuka M; Sato M
    Sci Rep; 2018 Aug; 8(1):12059. PubMed ID: 30104681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Creation of CRISPR-based germline-genome-engineered mice without ex vivo handling of zygotes by i-GONAD.
    Gurumurthy CB; Sato M; Nakamura A; Inui M; Kawano N; Islam MA; Ogiwara S; Takabayashi S; Matsuyama M; Nakagawa S; Miura H; Ohtsuka M
    Nat Protoc; 2019 Aug; 14(8):2452-2482. PubMed ID: 31341289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. i-GONAD: A method for generating genome-edited animals without ex vivo handling of embryos.
    Ohtsuka M; Sato M
    Dev Growth Differ; 2019 Jun; 61(5):306-315. PubMed ID: 31198998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent Advances in the Production of Genome-Edited Rats.
    Sato M; Nakamura S; Inada E; Takabayashi S
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful production of genome-edited rats by the rGONAD method.
    Kobayashi T; Namba M; Koyano T; Fukushima M; Sato M; Ohtsuka M; Matsuyama M
    BMC Biotechnol; 2018 Apr; 18(1):19. PubMed ID: 29606116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modification of
    Kobayashi Y; Aoshima T; Ito R; Shinmura R; Ohtsuka M; Akasaka E; Sato M; Takabayashi S
    Cells; 2020 Apr; 9(4):. PubMed ID: 32295056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. i-GONAD: a robust method for in situ germline genome engineering using CRISPR nucleases.
    Ohtsuka M; Sato M; Miura H; Takabayashi S; Matsuyama M; Koyano T; Arifin N; Nakamura S; Wada K; Gurumurthy CB
    Genome Biol; 2018 Feb; 19(1):25. PubMed ID: 29482575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GONAD: Genome-editing via Oviductal Nucleic Acids Delivery system: a novel microinjection independent genome engineering method in mice.
    Takahashi G; Gurumurthy CB; Wada K; Miura H; Sato M; Ohtsuka M
    Sci Rep; 2015 Jun; 5():11406. PubMed ID: 26096991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple and Consecutive Genome Editing Using i-GONAD and Breeding Enrichment Facilitates the Production of Genetically Modified Mice.
    Melo-Silva CR; Knudson CJ; Tang L; Kafle S; Springer LE; Choi J; Snyder CM; Wang Y; Kim SV; Sigal LJ
    Cells; 2023 May; 12(9):. PubMed ID: 37174743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel technique for large-fragment knock-in animal production without ex vivo handling of zygotes.
    Abe M; Nakatsukasa E; Natsume R; Hamada S; Sakimura K; Watabe AM; Ohtsuka T
    Sci Rep; 2023 Feb; 13(1):2245. PubMed ID: 36755180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR/Cas9-mediated genome editing of Schistosoma mansoni acetylcholinesterase.
    You H; Mayer JU; Johnston RL; Sivakumaran H; Ranasinghe S; Rivera V; Kondrashova O; Koufariotis LT; Du X; Driguez P; French JD; Waddell N; Duke MG; Ittiprasert W; Mann VH; Brindley PJ; Jones MK; McManus DP
    FASEB J; 2021 Jan; 35(1):e21205. PubMed ID: 33337558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo genome editing targeted towards the female reproductive system.
    Sato M; Ohtsuka M; Nakamura S; Sakurai T; Watanabe S; Gurumurthy CB
    Arch Pharm Res; 2018 Sep; 41(9):898-910. PubMed ID: 29974342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of Flag/DYKDDDDK Epitope Tag Knock-In Mice Using
    Aoto K; Takabayashi S; Mutoh H; Saitsu H
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combi-CRISPR: combination of NHEJ and HDR provides efficient and precise plasmid-based knock-ins in mice and rats.
    Yoshimi K; Oka Y; Miyasaka Y; Kotani Y; Yasumura M; Uno Y; Hattori K; Tanigawa A; Sato M; Oya M; Nakamura K; Matsushita N; Kobayashi K; Mashimo T
    Hum Genet; 2021 Feb; 140(2):277-287. PubMed ID: 32617796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An efficient i-GONAD method for creating and maintaining lethal mutant mice using an inversion balancer identified from the C3H/HeJJcl strain.
    Iwata S; Sasaki T; Nagahara M; Iwamoto T
    G3 (Bethesda); 2021 Aug; 11(8):. PubMed ID: 34849815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.